Facilitating Communication Study

NACompletedINTERVENTIONAL
Enrollment

977

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

October 26, 2023

Study Completion Date

June 30, 2024

Conditions
Chronic DiseaseNeoplasm MetastasisLung NeoplasmPulmonary Disease, Chronic ObstructiveHeart Failure, CongestiveLiver CirrhosisKidney Failure, ChronicMultiple Organ FailureHealth Care Quality, Access, and EvaluationIntensive Care UnitsPalliative Care, Health ServicesPalliative Care, Patient CareLung DiseasesCerebrovascular DisordersBrain Injuries
Interventions
BEHAVIORAL

Facilitator-Based Intervention

Facilitators interact in person or by telephone with patients, family, and clinicians both during and following the patient's ICU stay for 3 months. In-person contacts include visits to patients' homes and/or care facilities; phone contacts include calls to patients, families and clinicians. Patients and families have access to facilitators through phone and email 5 days per week. Facilitators may attend clinic visits with patients. In addition to checking directly with patients/families during regular contacts, facilitators also access the electronic health record to ensure they have accurate information about appointments and treatment plans and to document key points for the clinical team. Facilitators encourage referral to inpatient or outpatient palliative care services when needs are identified.

Trial Locations (3)

98104

UW Medicine - Harborview Medical Center, Seattle

98133

University of Washington Medical Center - Northwest, Seattle

98195

University of Washington Medical Center - Montlake, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT03721952 - Facilitating Communication Study | Biotech Hunter | Biotech Hunter